Healthcare Programmatic Advertising Merger Being Adblocked by FTC

Cozen O'Connor
Contact
LinkedIn
Facebook
X
Send
Embed

Cozen O'Connor

  • The FTC filed an administrative complaint seeking to block IQVIA Holdings Inc.’s proposed acquisition of Propel Media, Inc., alleging that its consummation would negatively impact competition in programmatic advertising for prescription drugs to healthcare professionals.
  • According to the complaint, a merger between IQVIA, the world’s largest healthcare data provider, and Propel, the owner of a leading demand-side platform that targets healthcare professionals (HCPs) with advertising for pharmaceutical drugs and other healthcare products, would substantially lessen competition in the already concentrated HCP programmatic healthcare advertising industry. In addition, the complaint alleges that IQVIA would also be incentivized to withhold key healthcare data that is necessary for programmatic advertising from rival demand-side platforms.
  • The FTC will seek a temporary restraining order and preliminary injunction in federal district court to pause the acquisition pending the agency’s administrative proceeding.
Send Print Report

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Cozen O'Connor | Attorney Advertising

Written by:

Cozen O'Connor
Cozen O'Connor
Contact
more
less

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign Up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide